French decree regarding the “direct access”: a half-hearted step forward for pharmaceutical innovations

Start
Publication of the French decree regarding the experimentation of the “direct access” to pharmaceutical products with anticipated reimbursement: a half-hearted step forward for pharmaceutical innovations….
By: Hogan Lovells
Previous Story

The UK’s Proposed Laws to Tackle Consumer Subscription Traps – 5 Things You Need to Know

Next Story

Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy